About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
BOARD MEETINGS
Board
Meetings
Parnax Lab Ltd.
From Date
:
To Date
:
Source Date
Board Meeting Date
Details
03-Nov-2025
14-Nov-2025
Quarterly Results
05-Aug-2025
13-Aug-2025
Quarterly Results
20-May-2025
27-May-2025
Audited Results
31-Jan-2025
10-Feb-2025
Quarterly Results
06-Nov-2024
14-Nov-2024
Quarterly Results
05-Aug-2024
14-Aug-2024
Quarterly Results
23-May-2024
30-May-2024
Quarterly Results
05-Feb-2024
13-Feb-2024
Quarterly Results
02-Nov-2023
09-Nov-2023
Quarterly Results
03-Aug-2023
11-Aug-2023
Quarterly Results
23-May-2023
30-May-2023
Audited Results
06-Feb-2023
14-Feb-2023
Quarterly Results
07-Nov-2022
14-Nov-2022
Quarterly Results
03-Aug-2022
10-Aug-2022
Quarterly Results
23-May-2022
30-May-2022
Audited Results
07-Feb-2022
14-Feb-2022
Quarterly Results
29-Dec-2021
01-Jan-2022
Issue Of Warrants Inter alia, 1. To consider and evaluate proposals for raising funds by way of issue of warrants convertible into equity shares through preferential issue including determination of issue price as may be permitted under applicable laws, subject to the approval of the shareholders of the Company; 2. To confirm the Date, Time, and Notice for convening Extra-Ordinary General Meeting ('EOGM') of the members of the Company; 3. Any other matter, if required with the permission of the chair
08-Nov-2021
13-Nov-2021
Quarterly Results
06-Aug-2021
14-Aug-2021
Quarterly Results
23-Jun-2021
30-Jun-2021
Quarterly Results
Page
1
of
5
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.